KGET OTC
CaliPharms, Inc.
1W: +3900.0%
1M: +0.0%
3M: +0.0%
YTD: +3900.0%
1Y: +3900.0%
3Y: +3900.0%
5Y: -80.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$162K
-1445.3% ▼
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$162K
-1445.3% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$4K
+512.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2013 | FY2015 | FY2016 | FY2017 |
|---|---|---|---|---|
| — Operating Activities — | ||||
| Net Income | -$213K | -$959K | -$442K | -$1M |
| Depreciation & Amort. | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in Working Capital | $142K | $370K | $425K | $691K |
| Other Non-Cash Items | $36K | $536K | $6K | $570K |
| Operating Cash Flow | -$36K | -$53K | -$10K | -$162K |
| — Investing Activities — | ||||
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| — Financing Activities — | ||||
| Net Debt Issuance | $25K | $0 | $0 | $128K |
| Stock Repurchased | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Financing | $11K | $44K | $11K | $0 |
| Financing Cash Flow | $36K | $44K | $11K | $166K |
| Net Change in Cash | $366 | -$9K | $603 | $4K |
| Cash End of Period | $406 | -$9K | $603 | $4K |
| Free Cash Flow | -$36K | -$53K | -$10K | -$162K |